Document is current

Any future updates will be listed below

A development of chimeric VEGFR2 TK inhibitor based on two ligand conformers from PDB: 1Y6A complex – Medicinal chemistry consequences of a TKs analysis

Crossref DOI link: https://doi.org/10.1016/j.ejmech.2013.11.023

Published Print: 2014-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

About CrossMark